Infection Prevention
Increasing use of injectables challenges programs to prevent
transmission of the AIDS-causing human immunodeficiency virus
(HIV), hepatitis B, and other blood-borne infections to clients,
clinic staff, and the public through contaminated needles and
syringes. Injections for contraception are a small proportion of
the total number of injections given, which include
immunizations, vitamins, antibiotics, and others. Thus any risk
from contraceptive injections is a very small part of a large
problem. For example, the WHO Expanded Program on Immunization
(EPI) estimates that children under five receive over 5.5 billion
injections of all types each year, and about half of these
injections risk infection of some sort (345).
Training must address common mistakes that providers make—for example,
giving several clients injections with the same needle and syringe without
sterilizing or disinfecting the equipment (see sidebar, Five
Basic Steps of Infection Prevention: Do's and Don'ts). EPI
has estimated the risk of infection if all providers reused each needle
and syringe one time for immunizations without sterilizing or disinfecting
them. (EPI recommends that infants and women of childbearing age each
receive five immunizations.) In areas such as sub-Saharan Africa, where
the prevalence of hepatitis B is about 10%, 260 per 100,000 fully immunized
infants would be infected with hepatitis B. In areas with an intermediate
prevalence of HIV infection of 1% among pregnant women, three infants
and 12 women per 100,000 would be infected with HIV (16).
Both donors and family planning clients prefer disposable
needles and syringes to reusable equipment. Clients may be
reassured when providers use a new needle and syringe for an
injection. In Kenya, for example, family planning clients feared
that some providers were reusing needles and syringes without
sterilizing them. In response, the Family Planning Association of
Kenya (FPAK) sells disposable needles and syringes to clients,
who then hand them to the FPAK provider giving the injection
(144).
The choice of reusable or disposable equipment may depend on
cost. EPI estimates that at low volume—five injections per day,
for example—costs are about equal. As volume increases, reusable
equipment becomes cheaper. In clinics giving 50 injections per
day, for example, disposable equipment costs $0.05 per injection
and reusable equipment, $0.01 per injection. In addition to the
workload, costs depend on procurement costs, the cost of fuel for
sterilization and disposal, and the lifespan of the equipment
(344). USAID and UNFPA, which provide supplies free of charge,
ship injectables with disposable equipment (55, 118).
Infections may be transmitted through improper storage of
vials containing several doses of injectable. For example,
clinics operating once a week may store partially used vials for
one or two weeks. To avoid this problem, use of one-dose vials is
recommended.
Both motivation and supervision are essential to infection
prevention. Understanding their own risk of infection and the
risk to clients can motivate providers to follow safe procedures.
In one study of immunizations, for example, providers suffered
one needlestick for every 500 injections (294). If stuck with a
needle used on a client infected with hepatitis B, 5% to 27% of
providers become infected (96). Also, supervisors need to ensure
a steady supply of equipment, enforce procedures for infection
prevention, and account for disposable equipment after its use
(305).